TR200100628T2 - Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler. - Google Patents
Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler.Info
- Publication number
- TR200100628T2 TR200100628T2 TR2001/00628T TR200100628T TR200100628T2 TR 200100628 T2 TR200100628 T2 TR 200100628T2 TR 2001/00628 T TR2001/00628 T TR 2001/00628T TR 200100628 T TR200100628 T TR 200100628T TR 200100628 T2 TR200100628 T2 TR 200100628T2
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- oral
- mucosa
- agents
- safe
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 239000007788 liquid Substances 0.000 title abstract 2
- 230000003232 mucoadhesive effect Effects 0.000 title 1
- 210000004877 mucosa Anatomy 0.000 title 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000000241 respiratory effect Effects 0.000 abstract 2
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000003434 antitussive agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- -1 bronsodilators Substances 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- 229940124581 decongestants Drugs 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 229940066493 expectorants Drugs 0.000 abstract 1
- 229940125695 gastrointestinal agent Drugs 0.000 abstract 1
- 239000004083 gastrointestinal agent Substances 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002200 mouth mucosa Anatomy 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 abstract 1
- 238000004062 sedimentation Methods 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
- 239000004408 titanium dioxide Substances 0.000 abstract 1
- 230000001960 triggered effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Photolithography (AREA)
Abstract
Mevcut bulus, bilesimin agirligina göre yaklasik %2 ila yaklasik %50 titanyum dioksit koloidal parçaciklari ve mide-bagirsak maddeleri, analjezikler, dekonjestanlar, ekspektoranlar, antitüsifler, antihistaminler, bronsodilatörler, topikal anestetikler, algi maddeleri, oral bakim maddeleri, çesitli solunum maddeleri, ve bunlarin karisimlarindan olusan gruptan seçilen bir farmasötik aktif maddenin güvenli ve etkili miktarini içeren bir oral veya oral mukozada tutunan sulu sivi farmasötik bilesim ile ilgilidir; ki burada bilesim yaklasik 48 saat sonra ölçülen yaklasik 0.90'dan daha büyük bir çökme hacmi oranina sahiptir ve bilesimin tetiklenmis viskozite orani en az yaklasik 1.2'dir. Mevcut bulus ayrica, yukaridaki bilesimin güvenli ve etkili bir miktarinin uygulanmasi ile, beslenme kanali veya nasal mukozanin kaplanmasi, özellikle üst solunum sistemi enfeksiyonlari ve üst solunum sistemi doku tahrisi ve tahribinin önlenmesi ve tedavi edilmesi için bir yöntemle ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9757898P | 1998-08-24 | 1998-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100628T2 true TR200100628T2 (tr) | 2001-10-22 |
Family
ID=22264129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00628T TR200100628T2 (tr) | 1998-08-24 | 1999-08-24 | Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler. |
Country Status (17)
Country | Link |
---|---|
US (1) | US6319513B1 (tr) |
EP (1) | EP1107733B1 (tr) |
JP (1) | JP2002523354A (tr) |
KR (1) | KR100413877B1 (tr) |
CN (1) | CN1195494C (tr) |
AT (1) | ATE300282T1 (tr) |
AU (1) | AU761968B2 (tr) |
BR (1) | BR9913178B1 (tr) |
CA (1) | CA2338704C (tr) |
CO (1) | CO5140082A1 (tr) |
DE (1) | DE69926377T2 (tr) |
HU (1) | HUP0103388A3 (tr) |
ID (1) | ID29576A (tr) |
NO (1) | NO20010832D0 (tr) |
PE (1) | PE20000862A1 (tr) |
TR (1) | TR200100628T2 (tr) |
WO (1) | WO2000010529A1 (tr) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223416B2 (en) * | 1999-06-28 | 2007-05-29 | Minu, L.L.C. | Topical composition |
JP4639569B2 (ja) * | 1999-07-02 | 2011-02-23 | 三菱瓦斯化学株式会社 | 歯牙漂白剤組成物および変色歯牙漂白方法 |
US20020061281A1 (en) * | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
US20060083691A1 (en) * | 2000-05-10 | 2006-04-20 | Wermeling Daniel P | Intranasal opioid compositions, delivery devices and methods of using same |
WO2002041837A2 (en) * | 2000-11-22 | 2002-05-30 | Rxkinetix, Inc. | Treatment of mucositis |
US7927600B2 (en) * | 2001-03-30 | 2011-04-19 | Emile Loria | Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
FR2822709B1 (fr) * | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
EP1421940A4 (en) * | 2001-08-09 | 2006-02-08 | Sekisui Chemical Co Ltd | MEDICAL COMPOSITION FOR EXTERNAL USE FOR THE TREATMENT OF DERMATOSES |
CA2458219A1 (en) * | 2001-08-24 | 2003-03-06 | Mintaco Inc. | Oral rinse for treatment or prevention of bacterial and fungal infection |
US20080182841A1 (en) * | 2001-10-29 | 2008-07-31 | Levine Howard L | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
US8425892B2 (en) * | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
CA2467763C (en) * | 2001-12-21 | 2011-09-13 | Alcon, Inc. | Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
PL212123B1 (pl) * | 2002-01-15 | 2012-08-31 | Ucb Farchim Sa | Doustna kompozycja farmaceutyczna |
BG65734B1 (bg) * | 2002-02-22 | 2009-09-30 | Био Терапютикс - Еоод | Течен мукоадхезивен фармацевтичен състав |
US20030166732A1 (en) * | 2002-02-27 | 2003-09-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
AU2003224890A1 (en) * | 2002-04-08 | 2003-10-27 | Lavipharm Laboratories Inc. | Drug-complex microparticles and methods of making/using same |
KR20050005437A (ko) * | 2002-04-09 | 2005-01-13 | 플라멜 테크놀로지스 | 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제 |
US6919348B2 (en) * | 2002-05-02 | 2005-07-19 | Edward T. Wei | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
WO2003094968A2 (en) * | 2002-05-07 | 2003-11-20 | Altana Pharma Ag | Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases |
GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
CN100341498C (zh) | 2003-01-21 | 2007-10-10 | 千寿制药株式会社 | 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水成液制剂 |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US20040242729A1 (en) * | 2003-05-30 | 2004-12-02 | 3M Innovative Properties Company | Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
US7459146B2 (en) * | 2003-05-30 | 2008-12-02 | 3M Innovative Properties Company | Stabilized aerosol dispersions |
US7109247B2 (en) | 2003-05-30 | 2006-09-19 | 3M Innovative Properties Company | Stabilized particle dispersions containing nanoparticles |
US20050031700A1 (en) * | 2003-07-18 | 2005-02-10 | Sanatarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050154343A1 (en) * | 2004-01-14 | 2005-07-14 | Mohinder Singh | Soft tip applicator for relieving mouth pain |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050266031A1 (en) | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
US7482378B2 (en) * | 2004-05-28 | 2009-01-27 | Millenium Specialty Chemicals, Inc. | Physiological cooling compositions |
WO2006020190A1 (en) * | 2004-07-16 | 2006-02-23 | Richard Plymale | Dentifrice composition |
US20060046998A1 (en) * | 2004-08-25 | 2006-03-02 | Fairfield Clinical Trials, Llc | Method of treatment of gastroesophageal reflux disease and laryngopharyngeal reflux disease |
ES2704482T3 (es) | 2004-11-24 | 2019-03-18 | Meda Pharmaceuticals Inc | Composiciones que comprenden azelastina y sus métodos de uso |
US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US20060210482A1 (en) * | 2005-03-18 | 2006-09-21 | John Cassara | Chemical composition and method for cold and sinus relief |
US7985743B1 (en) * | 2005-07-22 | 2011-07-26 | Gene A. Tabish | Topical pain reliever and method of making the same |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
DK1965787T3 (da) * | 2005-11-30 | 2013-06-03 | Endo Pharmaceuticals Inc | Behandling af xerostomi med en svovlindeholdende antioxidant |
DOP2006000274A (es) * | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
US20070238750A1 (en) * | 2006-04-07 | 2007-10-11 | Michalis Nicolaou | Pure isomers of tritoqualine |
US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
EP2559434A3 (en) * | 2007-02-12 | 2013-05-29 | Mike Nicolaou | Treatment of COPD using a histidine decarboxylase inhibitor sole or combined with an anti-H1 drug or with a leucotriene receptor antagonist |
WO2008109018A1 (en) * | 2007-03-02 | 2008-09-12 | Meda Pharmaceuticals Inc. | Compositions comprising carisoprodol and methods of use thereof |
AU2014201068B2 (en) * | 2007-06-08 | 2016-07-07 | The Procter & Gamble Company | Natural honey-containing compositions and method of preparation |
ES2610603T3 (es) * | 2007-06-08 | 2017-04-28 | The Procter & Gamble Company | Composiciones que contienen miel natural y método de preparación |
ITMI20071623A1 (it) * | 2007-08-03 | 2009-02-04 | Vetagro S R L | Composizione sinergica comprendente sostanze aromatizzanti ed acidi organici, e relativo uso |
MX349677B (es) | 2007-11-13 | 2017-08-08 | Meritage Pharma Inc | Composiciones corticosteroides. |
KR20210107137A (ko) | 2008-04-21 | 2021-08-31 | 오토노미, 인코포레이티드 | 귀 질환 및 병태를 치료하기 위한 귀 조제물 |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
GB0807621D0 (en) * | 2008-04-25 | 2008-06-04 | Ineos Healthcare Ltd | Use |
CA2731769C (en) | 2008-07-21 | 2013-09-10 | Otonomy, Inc. | Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
US7914828B2 (en) * | 2008-10-17 | 2011-03-29 | Levine Brian M | Combination herbal product to benefit respiratory tract |
GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US8361519B2 (en) | 2010-11-18 | 2013-01-29 | Aadvantics Pharmaceuticals, Inc. | Combination herbal product to benefit respiratory tract in people exposed to smoke |
US20140213644A1 (en) * | 2010-12-30 | 2014-07-31 | Ziv Harish | Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome |
WO2014087419A1 (en) * | 2012-12-06 | 2014-06-12 | Colgate-Palmolive Company | Oral gel for sensitivity and tooth pain |
EP3061501A1 (en) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
EP3117825A1 (en) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Oral formulation comprising berberine and morus alba extract |
AU2016298307A1 (en) | 2015-07-28 | 2018-02-15 | Otonomy, Inc. | TrkB or TrkC agonist compositions and methods for the treatment of OTIC conditions |
CA3009072A1 (en) * | 2015-12-30 | 2017-07-06 | Colgate-Palmolive Company | Mucin coated silica for bacterial aggregation |
CA3029281A1 (en) | 2016-06-29 | 2018-01-04 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
US10583081B1 (en) * | 2017-11-27 | 2020-03-10 | Richard A. Myers | Apparatus and formulation for treating mouth ulcers |
WO2019154895A1 (en) | 2018-02-08 | 2019-08-15 | Strekin Ag | Gel formulation for preventing or treating hearing loss |
EP3817719A1 (en) * | 2018-07-02 | 2021-05-12 | Bayer HealthCare LLC | Stable pharmaceutical formulations of oxymetazoline |
JP7164700B2 (ja) | 2018-09-11 | 2022-11-01 | リードバイオセラピューティクスリミテッド | 粘膜付着性分散ナノ粒子系およびその製造方法 |
EP3965886A4 (en) * | 2019-02-15 | 2023-06-07 | Ferrer Medical Innovations, LLC | NASAL SPRAY COMPOSITIONS AND RELATED METHODS OF TREATMENT |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3352752A (en) | 1963-07-25 | 1967-11-14 | Tintex Corp | Intestinal adsorbent compositions |
JPS589083B2 (ja) | 1975-05-30 | 1983-02-18 | 武田薬品工業株式会社 | シヨウリユウザイノセイゾウホウ |
FR2346017A1 (fr) | 1975-10-23 | 1977-10-28 | Rech Applic Scient | Composition therapeutique pour le traitement des affections du tractus gastro-intestinal |
FR2502956A1 (fr) | 1981-04-01 | 1982-10-08 | Human Pharm Sa Laboratoires | Composition therapeutique utile comme topique digestif |
US4427681A (en) | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
JPS61106509A (ja) * | 1984-10-29 | 1986-05-24 | Fujisawa Pharmaceut Co Ltd | 鼻腔用医薬組成物 |
AU594765B2 (en) | 1986-05-16 | 1990-03-15 | Chugai Seiyaku Kabushiki Kaisha | Sucralfate preparations for applications on esophagus mucosa |
US5464828A (en) | 1988-03-02 | 1995-11-07 | Chugai Pharmaceutical Co., Ltd. | Aqueous suspension of sucralfate |
US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5047244A (en) | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
EP0452334A4 (en) | 1989-10-31 | 1991-12-11 | Watson Laboratoires, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
JPH0639368B2 (ja) | 1990-02-28 | 1994-05-25 | 株式会社萩原技研 | シリカゲルを母体とした抗菌性組生物 |
GB9025710D0 (en) | 1990-11-27 | 1991-01-09 | Beecham Group Plc | Novel treatment |
CA2110376C (en) | 1991-06-07 | 2003-02-11 | Adrianus J. Wittebrood | Pharmaceutical enema preparation |
IT1251153B (it) | 1991-08-06 | 1995-05-04 | Vectorpharma Int | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
JPH0725769A (ja) * | 1992-10-20 | 1995-01-27 | Fuji Chem Ind Co Ltd | アロプリノール医薬用液剤ならびにその製造法 |
FR2710265B1 (fr) | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
US5670163A (en) | 1994-06-20 | 1997-09-23 | Kv Pharmaceuticals Company | Long acting GI and esophageal protectant |
US5554379A (en) | 1994-06-20 | 1996-09-10 | Kv Pharmaceutical Company | Long acting GI and esophageal protectant |
US5554380A (en) | 1994-08-04 | 1996-09-10 | Kv Pharmaceutical Company | Bioadhesive pharmaceutical delivery system |
US5585108A (en) | 1994-12-30 | 1996-12-17 | Nanosystems L.L.C. | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
US5466440A (en) | 1994-12-30 | 1995-11-14 | Eastman Kodak Company | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays |
JP3927253B2 (ja) * | 1995-02-02 | 2007-06-06 | 中外製薬株式会社 | スクラルファート製剤 |
US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
IT1275955B1 (it) * | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
FR2739558B1 (fr) | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
-
1999
- 1999-07-27 US US09/361,533 patent/US6319513B1/en not_active Expired - Lifetime
- 1999-08-24 CN CNB998098604A patent/CN1195494C/zh not_active Expired - Fee Related
- 1999-08-24 ID IDW20010449A patent/ID29576A/id unknown
- 1999-08-24 TR TR2001/00628T patent/TR200100628T2/tr unknown
- 1999-08-24 KR KR10-2001-7001965A patent/KR100413877B1/ko not_active IP Right Cessation
- 1999-08-24 DE DE69926377T patent/DE69926377T2/de not_active Expired - Lifetime
- 1999-08-24 CA CA002338704A patent/CA2338704C/en not_active Expired - Fee Related
- 1999-08-24 EP EP99942429A patent/EP1107733B1/en not_active Expired - Lifetime
- 1999-08-24 BR BRPI9913178-1A patent/BR9913178B1/pt not_active IP Right Cessation
- 1999-08-24 PE PE1999000848A patent/PE20000862A1/es not_active Application Discontinuation
- 1999-08-24 JP JP2000565851A patent/JP2002523354A/ja active Pending
- 1999-08-24 AU AU55809/99A patent/AU761968B2/en not_active Ceased
- 1999-08-24 AT AT99942429T patent/ATE300282T1/de not_active IP Right Cessation
- 1999-08-24 WO PCT/US1999/019202 patent/WO2000010529A1/en not_active Application Discontinuation
- 1999-08-24 CO CO99053437A patent/CO5140082A1/es unknown
- 1999-08-24 HU HU0103388A patent/HUP0103388A3/hu unknown
-
2001
- 2001-02-19 NO NO20010832A patent/NO20010832D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5580999A (en) | 2000-03-14 |
WO2000010529A1 (en) | 2000-03-02 |
US6319513B1 (en) | 2001-11-20 |
BR9913178B1 (pt) | 2014-11-25 |
CA2338704C (en) | 2004-11-02 |
KR20010072678A (ko) | 2001-07-31 |
HUP0103388A2 (hu) | 2002-01-28 |
NO20010832L (no) | 2001-02-19 |
DE69926377D1 (de) | 2005-09-01 |
KR100413877B1 (ko) | 2004-01-07 |
CN1313756A (zh) | 2001-09-19 |
CO5140082A1 (es) | 2002-03-22 |
NO20010832D0 (no) | 2001-02-19 |
AU761968B2 (en) | 2003-06-12 |
CA2338704A1 (en) | 2000-03-02 |
DE69926377T2 (de) | 2006-06-01 |
CN1195494C (zh) | 2005-04-06 |
BR9913178A (pt) | 2001-05-15 |
PE20000862A1 (es) | 2000-09-13 |
EP1107733A1 (en) | 2001-06-20 |
JP2002523354A (ja) | 2002-07-30 |
EP1107733B1 (en) | 2005-07-27 |
ATE300282T1 (de) | 2005-08-15 |
ID29576A (id) | 2001-09-06 |
HUP0103388A3 (en) | 2006-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100628T2 (tr) | Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler. | |
TR200100569T2 (tr) | Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler | |
EP2346472B1 (en) | Tooth remineralisation | |
ATE250937T1 (de) | Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa | |
DE69518334T2 (de) | Pharmazeutische aerosol welche mindestens ein zucker enthält | |
CA2238271A1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
FI944123A (fi) | Farmaseuttiset inhalaatiokoostumukset | |
TR200100629T2 (tr) | Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler | |
NO306894B1 (no) | Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet | |
CA2136404A1 (fr) | Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale | |
TR200100566T2 (tr) | Mukozaya yapışan(muko-adhesif)oral sıvı bileşimler | |
WO2001012128A3 (en) | Antibacterial agents for the treatment of acute mucosal infections | |
CA2348474A1 (en) | Pharmaceutically active composition and dispensing device |